References
- 1.YANG Y,ZHANG G Z,LIU T,et al.Characteristics and regulatory mechanisms of cholestatic liver injury caused by Chinese herbal medicines[J].Chin J Exp Tradit Med Form,2024,30(23):64-71.
- 2.SONG S L,LI X,GENG C,et al.Uncovering key molecules and immune landscape in cholestatic liver injury:Implications for pathogenesis and drug therapy[J].Front Pharmacol,2023,14:1171512.
- 3.ZHANG Y D,LIU Y,HUO W,et al.The role of miRNA and long noncoding RNA in cholestatic liver diseases[J].Am J Pathol,2024,194(6):879-893.
- 4.MÉNDEZ-SÁNCHEZ N,CORONEL-CASTILLO C E,ORDOÑEZ-VÁZQUEZ A L.Current therapies for cholestatic diseases[J].Biomedicines,2023,11(6):1713.
- 5.CIFUENTES-SILVA E,CABELLO-VERRUGIO C.Bile acids as signaling molecules:Role of ursodeoxycholic acid in cholestatic liver disease[J].Curr Protein Pept Sci,2024,25(3):206-214.
- 6.SUN X L,HU X,ZHANG Y T.Clinical application of ursodeoxycholic acid[J].Chin J Pharmacovigil,2022,19(10):1149-1153.
- 7.WANG J,OUYANG B C.Advances in pharmacology and pharmacokinetics of Yinchenhao decoction in prevention and treatment of liver diseases[J].Drug Eval Res,2021,44(3):628-637.
- 8.CUI F C,ZUO L.Clinical observation of modified Yinchenhao decoction combined with ursodeoxycholic acid in the treatment of cholestasis liver disease with combined syndrome of dampness and blood stasis[J].Henan Tradit Chin Med,2023,43(7):992-996.
- 9.LUO H B,HE W Z,LI D S,et al.Clinical effect of Jiawei Yinchenhao decoction on nonalcoholic fatty liver disease and its influence on intestinal flora[J].World J Integr Tradit West Med,2021,16(9):1746-1750.
- 10.ZUO L,CUI F C.Clinical study on supplemented Yinchenhao decoction in the treatment of cirrhosis with syndrome of dampness-heat internal accumulation[J].Henan Tradit Chin Med,2023,43(3):350-353.
- 11.YOKODA R T,RODRIGUEZ E A.Review:Pathogenesis of cholestatic liver diseases[J].World J Hepatol,2020,12(8):423-435.
- 12.FUCHS C D,TRAUNER M.Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology[J].Nat Rev Gastroenterol Hepatol,2022,19(7):432-450.
- 13.GHANBARINEJAD V,OMMATI M M,JIA Z P,et al.Disturbed mitochondrial redox state and tissue energy charge in cholestasis[J].J Biochem Mol Toxicol,2021,35(9):e22846.
- 14.CHEN J,ZHANG S J.The role of inflammation in cholestatic liver injury[J].J Inflamm Res,2023,16:4527-4540.
- 15.YU L L,LIU Y R,WANG S H,et al.Cholestasis:Exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies[J].Gut Microbes,2023,15(1):2181930.
- 16.HUANG LP,XU Y H,DENG M Z,et al.Research progress on chemical constituents,pharmacological mechanism and clinical application of Artemisiae Scopariae Herba[J].Nat Prod Res Dev,2021,33(4):676-690.
- 17.CHEN R,HE Z X,YAN Y,et al.Research progress on pharmacological and toxic effects of Gardeniae Fructus and its main components[J].Chin Tradit Herbal Drugs,2023,54(18):6092-6105.
- 18.ZHANG K X,YAO Q Y,WU F M,et al.Research progress on chemical constituents and pharmacological effects of medicinal plants in genus Rheum[J].Chin J New Drugs,2022,31(6):555-566.
- 19.FU Z W,LI Z X,HU P,et al.A practical method for the rapid detection and structural characterization of major constituents from traditional Chinese medical formulas:Analysis of multiple constituents in Yinchenhao Tang[J].Anal Methods,2015,7(11):4678-4690.
- 20.QIN C P,QIU Q,LI P F,et al.Research progress of classical prescription Yinchenhao decoction in treating hepatobiliary diseases and predictive analysis of quality markers[J].Chin Arch Tradit Chin Med,2024,42(4):208-214.
- 21.LING Q H,ZHENG Y Q,CHEN J J,et al.Clinical efficacy of modified Yinchenhao decoction combined with ursodeoxycholic acid in the treatment of primary biliary cholangitis and effect on FGF19[J].Shanghai J Tradit Chin Med,2020,54(S1):41-43.
- 22.WU L F,WANG Z M,HE K Q,et al.Chemical constituents and pharmacological effects of Paeoniae Radix Rubra:A review[J].Chin J Exp Tradit Med Form,2021,27(18):198-206.
- 23.ZHANG S R,ZHAO H S,TONG M R,et al.Chemical constituents,pharmacological effects of Moutan Cortex and predictive analysis on its quality marker(Q-Marker)[J].Chin Tradit Herbal Drugs,2022,53(16):5215-5224.
- 24.CHEN J P,ZHANG K X,LIU Y,et al.Research progress on chemical constituents and pharmacological actions of Rehmannia glutinosa[J].Chin Tradit Herbal Drugs,2021,52(6):1772-1784.
- 25.LI K D,CAO Z J,AO H.Research progress on chemical components and pharmacological effects of atractylodes[J].J Chengdu Univ Tradit Chin Med,2024,47(6):73-80.
- 26.LIU D W,HE L L,CUI N,et al.Research progress of chemical constituents,pharmacological action and quality marker prediction of Largehead Atractylodes Rhizome[J].Inf Tradit Chin Med,2024,41(1):65-78.
- 27.GUAN X T,YANG H N,ZHANG J C,et al.Research progress on chemical constituents and pharmacological effects of chenpi (dried tangerine peel)[J].Chin Arch Tradit Chin Med,2024,42(6):41-49,266.
- 28.LI W H,LI X J,ZHANG T,et al.Effect of Huoxue Qingjie Ling on bile acid metabolism of cholestatic liver disease rats[J].Shandong Med J,2020,60(19):21-24.
- 29.FENG K R,LI W X,WANG X Y,et al.Chemical components and pharmacological action for Salviae Miltiorrhizae Radix et Rhizoma and predictive analysis on quality markers[J].Chin Tradit Herbal Drugs,2022,53(2):609-618.
- 30.YUAN R Y K,WANG Q Q,HE J,et al.Research progress on pharmacological effects and mechanism of Pulsatilla chinensis[J].Drug Eval Res,2024,47(7):1421-1432.
- 31.CHEN S L,HAN L.Modern research progress on Patriniae[J].J Guangdong Pharm Univ,2017,33(6):816-821.
- 32.XIE R Q,WANG C F.Research progress on chemical constituents and pharmacological effects of prepared glycyrrhiza[J].Inf Tradit Chin Med,2023,40(4):84-89.
- 33.VITALE G,MATTIACCIO A,CONTI A,et al.Molecular and clinical links between drug-induced cholestasis and familial intrahepatic cholestasis[J].Int J Mol Sci,2023,24(6):5823.
- 34.WANG X,XIONG W Q,WANG X,et al.Ursolic acid attenuates cholestasis through NRF2-mediated regulation of UGT2B7 and BSEP/MRP2[J].Naunyn Schmiedebergs Arch Pharmacol,2024,397(4):2257-2267.
- 35.CHANG J H,PLISE E,CHEONG J,et al.Evaluating the in vitro inhibition of UGT1A1,OATP1B1,OATP1B3,MRP2,and BSEP in predicting drug-induced hyperbilirubinemia[J].Mol Pharm,2013,10(8):3067-3075.
- 36.PAN Q,ZHU G Y,XU Z Q,et al.Organic anion transporting polypeptide (OATP) 1B3 is a significant transporter for hepatic uptake of conjugated bile acids in humans[J].Cell Mol Gastroenterol Hepatol,2023,16(2):223-242.
- 37.DENK G U,SOROKA C J,MENNONE A,et al.Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis[J].Hepatology,2004,39(5):1382-1389.
- 38.YI Y X,DING Y,ZHANG Y,et al.Yinchenhao decoction ameliorates alpha-naphthylisothiocyanate induced intrahepatic cholestasis in rats by regulating phase Ⅱ metabolic enzymes and transporters[J].Front Pharmacol,2018,9:510.
- 39.KATAFUCHI T,MAKISHIMA M.Molecular basis of bile acid-FXR-FGF15/19 signaling axis[J].Int J Mol Sci,2022,23(11):6046.
- 40.XU Y,CHEN Y,XU Y Y,et al.Study on mechanism of modified Yinchenhao decoction on liver injury induced by α-naphthyl isothiocyanate in mice with cholestasis[J].Acad J Shanghai Univ Tradit Chin Med,2023,37(6):41-48.
- 41.KOH H,PARK G S,SHIN S M,et al.Mitochondrial mutations in cholestatic liver disease with biliary atresia[J].Sci Rep,2018,8(1):905.
- 42.LIU J J,LI Z L,SHANG H T.Study on Yinchenhao decoction regulating bile acid metabolism and intervening the mitochondrial DNA damage in liver cells of rats with obstructive jaundice[J].Tianjin Med J,2020,48(9):839-842.
- 43.KHAYAT M T,MOHAMMAD K A,MOHAMED G A,et al.γ-Mangostin abrogates AINT-induced cholestatic liver injury:Impact on Nrf2/NF-κB/NLRP3/Caspase-1/IL-1β/GSDMD signalling[J].Life Sci,2023,322:121663.
- 44.SHI Y,SU W T,ZHANG L,et al.TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation[J].Front Immunol,2021,11:609060.
- 45.LI W H,ZHANG G X,NIE W,et al.Therapeutic effect of modified Yinchenhao decoction on cholestatic liver disease in rats[J].Chin J Exp Tradit Med Form,2020,26(4):29-34.
- 46.YANG R K,ZHU S T,PISCHKE S E,et al.Bile and circulating HMGB1 contributes to systemic inflammation in obstructive jaundice[J].J Surg Res,2018,228:14-19.
- 47.MA W T,CHEN D K.Immunological abnormalities in patients with primary biliary cholangitis[J].Clin Sci,2019,133(6):741-760.
- 48.HE S M,FU J,WANG Z,et al.Analysis of the regulatory effect of Yinchenhao decoction on IL-6 and immune function after operation on obstructive jaundice with liver-gallbladder damp-heat syndrome[J].China Mod Doct,2022,60(14):143-145,149.
- 49.BELLEZZA I,GIAMBANCO I,MINELLI A,et al.Nrf2-Keap1 signaling in oxidative and reductive stress[J].Biochim Biophys Acta Mol Cell Res,2018,1865(5):721-733.
- 50.LI C L,LIU M G,DENG L,et al.Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-κB signaling pathways[J].Phytomedicine,2023,116:154899.
- 51.LIU J J,CHEN S,YUAN H X,et al.Effect of Yinchenhao decoction on renal oxidative stress injury in rats with obstructive jaundice and its mechanism of action based on the nuclear factor erythroid 2-related factor 2 signaling pathway[J].J Clin Hepatol,2023,39(5):1126-1133.
- 52.YUAN S.Mechanism of Yinchenhao decoction regulating Keap1 / Nrf2 pathway to prevent liver injury in rats with dampness heat syndrome of cholestatic liver disease[D].Jinan:Shandong University of Traditional Chinese Medicine,2022.
- 53.CUNNINGHAM R P,MOORE M P,DASHEK R J,et al.Critical role for hepatocyte-specific ENOS in NAFLD and NASH[J].Diabetes,2021,70(11):2476-2491.
- 54.ANAVI S,TIROSH O.iNOS as a metabolic enzyme under stress conditions[J].Free Radic Biol Med,2020,146:16-35.
- 55.CHEN S,LIU J J,SHANG H T,et al.Based on network pharmacology,molecular docking,and experiments to explore the mechanism of Yinchenhao decoction in regulating oxidative stress of obstructive jaundice[J].J Tianjin Med Univ,2021,27(6):595-602.
- 56.IURLARO R,MUÑOZ-PINEDO C.Cell death induced by endoplasmic reticulum stress[J].FEBS J,2016,283(14):2640-2652.
- 57.LI M S,ZHANG G X,WEI Y Y,et al.Experimental study on effects of Yinchenhao decoction on endoplasmic reticulum stress PERK pathway in cholestasis liver fibrosis rats[J].Chin J Tradit Med Sci Technol,2016,23(5):535-538.
- 58.CHENG C S,DONG W G.Aloe-emodin induces endoplasmic reticulum stress-dependent apoptosis in colorectal cancer cells[J].Med Sci Monit,2018,24:6331-6339.
- 59.LI M S,ZHANG G X,WEI Y Y,et al.Effects of Yinchenhao decoction on endoplasmic reticulum stress pathway of caspase-12 in hepatic fibrosis rats[J].World Chin Med,2016,11(9):1839-1841.
- 60.XU H B,SHEN X M,LI X K,et al.The natural product dehydrocurvularin induces apoptosis of gastric cancer cells by activating PARP-1 and caspase-3[J].Apoptosis,2023,28(3/4):525-538.
- 61.YU W J,ZHU H L,HUANG R X,et al.Roles of Cyt-C/Caspase-9/Caspase-3/Bax/Bcl-2 pathway in Cd-induced testicular injury in rats and the protective effect of quercetin[J].Toxicon,2024,237:107561.
- 62.WANG Y W,GUO Z,DU Z,et al.Comparative study of Yinchenhao decoction and Huangqi decoction by regulating apoptosis via the mitochondrial pathway in treatment and prevention of chronic cholestatic liver injury[J].China J Tradit Chin Med Pharm,2023,38(1):155-160.
- 63.ISHTEYAQUE S,YADAV K S,VERMA S,et al.CYP2E1 triggered GRP78/ATF6/CHOP signaling axis inhibit apoptosis and promotes progression of hepatocellular carcinoma[J].Arch Biochem Biophys,2023,745:109701.
- 64.XIANG C C,HAN F,SHI Y X.Research on activating transcription factor 6 pathway and its related factors' regulation on unfolded protein reaction in endoplasmic reticulum stress[J].Acta Anat Sin,2015,46(6):857-861.
- 65.SUN Y M,LIU H,LIU J J,et al.Influence of Yinchenhao decoction on the expression of ATF6/GRP78/CHOP apoptotic signaling pathway in hepatocyte of rats with obstructive jaundice[J].J Tianjin Med Univ,2023,29(3):252-257.
- 66.DUAN Y T,HUANG J J,SUN M J,et al.Poria cocos polysaccharide improves intestinal barrier function and maintains intestinal homeostasis in mice[J].Int J Biol Macromol,2023,249:125953.
- 67.HUANG L,LU T,ZHANG Y L,et al.Correlation between abnormal serum detection indicators of intestinal barrier function with metabolic diseases[J].Chongqing Med J,2024,53(24):3789-3792.
- 68.HAN B,LV X D,LIU G F,et al.Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis[J].Gut Microbes,2023,15(1):2232143.
- 69.ZHAO J L.Chinese herbs for clearing heat and removing dampness on expression of gpbar1 and FXR in intestinal mucosa of rats with obstructive jaundice[D].Dalian:Dalian Medical University,2019.
- 70.GONG H X,DONG H C,SU Y,et al.Effect of Dabupi decoction combined with oxaliplatin on intestinal barrier injury in tumor-bearing mice with gastric cancer based on TLR4/MyD88/NF-κB signaling pathway[J].Pharmacol Clin Chin Mater Med,2023,39(8):31-36.
- 71.LI J T,JIAO J Z,WEI H L,et al.Effect of Yinchenhao decoction on intestinal mucosal barrier and NF-κB in rats with acute intrahepatic cholestasis[J].Shaanxi J Tradit Chin Med,2019,40(5):547-549.
- 72.HOU X D,ZHU L,ZHANG G Q,et al.The therapeutic effect and the underlying mechanism of Yinchenhao decoction and its different modified combinations on estrogen induced cholestasis rats[J].Chin J Hosp Pharm,2017,37(15):1454-1458.
- 73.WU H B,SHE S F,LAN S Y.Mechanism of Yinzhihuang injection for intrahepatic cholestasis based on FXR[J]. Liaoning J Tradit Chin Med,2016,43(4):845-848.
- 74.MIAO Y H,SUN R F.Effect of Yinchenhao decoction on Th1/Th2 balance in patients with intrahepatic cholestasis of pregnancy[J].Chin J Integr Tradit West Med,2014,34(8):1017-1018.
- 75.FU H H.Value analysis of Yinchenhao decoction in the treatment of intrahepatic cholestasis of pregnancy[J].Pract Clin J Integr Tradit Chin West Med,2017,17(10):45-47.
- 76.YANG X B.Effect of Yinchenhao decoction on Th1/Th2 balance in patients with intrahepatic cholestasis of pregnancy[J].Mod J Integr Tradit Chin West Med,2019,28(17):1885-1887,1891.
- 77.CHEN W Z,XIONG Z H,HONG Q H,et al.Clinical efficacy of Jiawei Yinchenhao decoction combined with S-adenosylmethionine and its effects on serum TBA,IL-17 and TGF-β levels in patients with intrahepatic cholestasis of pregnancy[J].Zhejiang Med J,2020,42(22):2439-2442.
- 78.WANG S P,LI Y F,SUN X,et al.Efficacy of Yinchenhao decoction combined with ursodeoxycholic acid in the treatment of ICP and the effect of Th17/Treg imbalance on pregnancy outcome[J].Shaanxi J Tradit Chin Med,2023,44(8):1074-1077.
- 79.ZHU Z W,ZHU P S,MIAO M S.Evaluation of cholestatic liver disease animal model based on clinical syndrome characteristics of integrated traditional Chinese and Western medicine[J].J Clin Hepatol,2023,39(12):2959-2964.
- 80.WANG L L,ZHU Z W,ZHAO J H,et al.Mechanism of Yinchenhao Tang regulating pyroptosis to interfere with cholestatic liver injury[J].Chin J Exp Tradit Chin Med Form,2025,doi:.
- 81.ZHAO J H,ZHU Z W,WANG L L,et al.Investigation into mechanism of Yinchenhao decoction in modulating macrophage activation to combat cholestatic liver injury[J].Chin J Exp Tradit Chin Med Form,2025,doi:.
- 82.ZHU Z W,WANG L L,ZHAO J H,et al.Mechanism of Yinchenhao Tang regulating Fas/Caspase-8/Caspase-3 signaling pathway to improve cholestatic liver injury[J].Chin J Exp Tradit Chin Med Form,2025,doi:.
- 83.ZHU Z W,YANG Y,ZHAO J H,et al.Mechanism of Yinchenhao Tang in improving cholestatic liver injury by inhibiting TLR4/MyD88/NF-κB pathway through FXR[J].Chin J Exp Tradit Chin Med Form,2025,doi:.


